JUVIS Diet Investment Attraction Receiving Great Interest from PE and SI Firms View original image

Juviz Diet, known as the largest healthcare group in Korea, announced that it is preparing to attract external investment.


Juviz Diet has achieved high sales growth with a differentiated diet consulting service that successfully completed diets for celebrities such as Super Junior's Shindong, Huh Gak, singer Kangnam, Noh Yumin, and Chun Myunghoon, along with a diverse revenue structure including health functional foods, general foods, and device distribution, reaching 42.5 billion KRW in 2018 and 47.9 billion KRW in 2019.


In particular, operating profit and cash generation power have grown about tenfold, steadily maintaining growth through the operation of 30 directly managed stores nationwide and distribution business, establishing a dominant position in the diet healthcare market.


Following SARS and MERS, and recently COVID-19, public interest in health management in daily life has sharply increased, and the healthcare industry's growth is expected to accelerate. As a brand that has solidified its position in the diet sector of the healthcare industry for 18 years, Juviz Diet's investment attraction is receiving significant attention from PE and SI investors.


Juviz Diet, which recorded an operating profit of 14.2 billion KRW last year, posted an operating profit exceeding 6 billion KRW in the first quarter of 2020 despite the contraction of consumer economy due to COVID-19. With the launch of the new home-visit diet service 'Juviz At Home' on May 6, it is expected to expand into new business areas and forecast an operating profit of approximately 24 to 26 billion KRW for 2020.


The investment method is known to be proceeding within a 30-40% range through new share issuance and partial sale of existing shares. Juviz Diet, preparing for investment attraction in the fourth quarter of this year, is expected to have an investment valuation of about 250 to 280 billion KRW.



Juviz Diet, which selected Samsung Securities as its advisory firm to prepare for investment attraction, plans to invest the raised funds in launching overseas brands to explore broader overseas markets and grow into a comprehensive healthcare service company.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing